{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:57:07Z","timestamp":1775743027976,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":845,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1999,9]]},"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>:\u2002To evaluate the short\u2010term effects of rabeprazole 20 mg on endocrine parameters, in particular serum testosterone and cortisol, and on 24 h intragastric pH, H<jats:sup>+<\/jats:sup> activity and nocturnal gastric acid secretion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>:\u2002In this double\u2010blind, two\u2010period crossover study, 12 healthy young male volunteers were randomly given oral rabeprazole 20\u2003mg o.m. or placebo for 14 days. There was a washout period of at least 1 week between the two studies. The effects of rabeprazole and placebo on cortisol and testosterone (primary criteria), and on tri\u2010iodothyronine, thyroxine, 17\u03b2\u2010oestradiol, thyroid\u2010stimulating hormone, thyroxine\u2010binding protein, parathyroid hormone, insulin, glucagon, rennin, aldosterone, follicle\u2010stimulating hormone, luteotrophic hormone, prolactin, somatotrophic hormone, dehydroepiandrosterone, cortisol\u2010binding globulin and urinary 6\u2010\u03b2 hydroxycortisol were compared. Intragastric 24 h pH, 24 h H<jats:sup>+<\/jats:sup> activity and nocturnal gastric acid secretion were determined by pH probe and gastric aspiration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>:\u2002Rabeprazole produced no clinically relevant effects on endocrine function as assessed by measurement of serum testosterone, circadian serum cortisol levels, ACTH\u2010stimulated serum cortisol levels and 17 other endocrine function tests. Rabeprazole significantly increased the 24 h median pH values compared to placebo (on Days 7 and 14 median values ranged from 3.92 to 6.88 with rabeprazole and from 1.48 and 4.22 with placebo, <jats:italic>P<\/jats:italic> &lt; 0.001) and significantly decreased the integrated 24 h H<jats:sup>+<\/jats:sup> activity (<jats:italic>AUC<\/jats:italic><jats:sub>08\u201308<\/jats:sub>) from 343 mmol\/L\/h with placebo to 44 mmol\/L\/h with rabeprazole (<jats:italic>P<\/jats:italic> &lt; 0.001). Following cessation of dosing, intragastric pH levels decreased and H<jats:sup>+<\/jats:sup> activity increased, but acid secretion did not recover completely during the next 72 h. The mean value for nocturnal gastric acid secretion on Days 7 and 8 was 36 mmol\/6\u200ah with placebo and 5.6 mmol\/6\u200ah with rabeprazole (<jats:italic>P<\/jats:italic> &lt; 0.001). Rabeprazole was well tolerated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>:\u2002Rabeprazole did not influence endocrine function in healthy young male volunteers during short\u2010term dosing. Rabeprazole substantially increased intragastric pH over a 24 h period and significantly decreased intragastric acidity and nocturnal gastric acid secretion.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1999.00545.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:39:37Z","timestamp":1047353977000},"page":"1195-1203","source":"Crossref","is-referenced-by-count":14,"title":["The effects of oral rabeprazole on endocrine and gastric secretory function in healthy volunteers"],"prefix":"10.1111","volume":"13","author":[{"family":"Dammann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Burkhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(93)90133-K"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00394.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.36.22438"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"21553","DOI":"10.1016\/S0021-9258(20)80577-8","article-title":"Different biochemical modes of action of two irreversible H+\/K+\u2010ATPase inhibitors, omeprazole and E3810","volume":"268","author":"Morii M","year":"1993","journal-title":"J Biol Chem"},{"key":"e_1_2_5_6_2","unstructured":"HumphriesTJ.Duodenal ulcer. In: Van Ness MM Chobanian SJ eds. Manual of Clinical Problems in Gastroenterology 2nd edn. Boston: Little Brown 1994: 69\u201375."},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01537225"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01311234"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00399.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198901123200201"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00779.x"},{"key":"e_1_2_5_12_2","first-page":"99","article-title":"Effect of a proton pump inhibitor. E3810 on gastric pH\u201324 hr intragastric pH monitoring.","volume":"41","author":"Inoue M","year":"1994","journal-title":"Jap Arch Intern Med"},{"key":"e_1_2_5_13_2","first-page":"A161","article-title":"A low dose of new proton pump inhibitors LY\u2010307640 (E3810) effectively inhibits acid secretion in humans","volume":"110","author":"Kovacs TOG","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_5_14_2","first-page":"A47","article-title":"The effects of rabeprazole on 24\u2010hour intragastric acidity and plasma gastrin concentration in healthy subjects","volume":"39","author":"Blanshard C","year":"1996","journal-title":"Gut"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-3-370"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.27.10.1143"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00637598"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00329.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00089.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528609090932"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0700099"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00543980"},{"key":"e_1_2_5_23_2","unstructured":"HaynesRCJr.Adrenocorticotropic hormone: Adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of hormones. In: Gilman AG Rall TW Nies AS Taylor P eds. Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics 8th edn. New York: McGraw\u2010Hill 1991: 1431\u201362."},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0953-0673.1996.00359.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(85)80133-5"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1999.00545.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1999.00545.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1999.00545.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T23:04:52Z","timestamp":1698534292000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1999.00545.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["10.1046\/j.1365-2036.1999.00545.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1999.00545.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}